Sectoral Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Sectoral Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$821K	Sell	10,851 -2,634	-20%	-$150K	0.68%	38
2025 Q4	$570K	Buy	+13,485	New	+$755K	0.46%	60
2020 Q3	–	Sell	-1,780	Closed	-$618K	–	151
2020 Q2	$618K	Buy	+1,780	New	+$555K	0.06%	121
2018 Q4	–	Sell	-5,484	Closed	-$5.01M	–	125
2018 Q3	$5.01M	Buy	5,484 +576	+12%	+$492K	0.53%	53
2018 Q2	$3.6M	Sell	4,908 -1,686	-26%	-$1.94M	0.4%	58
2018 Q1	$10.5M	Sell	6,594 -1,260	-16%	-$1.62M	1.15%	32
2017 Q4	$7.04M	Buy	+7,854	New	+$4.65M	0.88%	33
2016 Q2	–	Sell	-851	Closed	-$175K	–	72
2016 Q1	$175K	Sell	851 -8,291	-91%	-$1.59M	0.01%	80
2015 Q4	$2.31M	Buy	9,142 +2,182	+31%	+$449K	0.1%	60
2015 Q3	$1.14M	Buy	6,960 +303	+5%	+$53.6K	0.05%	70
2015 Q2	$1.25M	Buy	6,657 +1,383	+26%	+$238K	0.05%	67
2015 Q1	$870K	Buy	+5,274	New	+$1.08M	0.03%	74

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sectoral Asset Management's NKTR Position: Q1 2026 in Review

Sectoral Asset Management reduced its Nektar Therapeutics (NKTR) stake by 20% in Q1 2026, selling an estimated $150K and leaving 10,851 shares worth $821K. The position accounts for 0.68% of the portfolio, ranked #38.

Sectoral Asset Management first reported a position in NKTR in Q1 2015 and has held it in 12 quarters since. The position peaked at $10.5M in Q1 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

Sectoral Asset Management held 10,851 shares of Nektar Therapeutics worth $821K as of Q1 2026.
Sectoral Asset Management sold 2,634 Nektar Therapeutics shares in Q1 2026, an estimated $150K.
Nektar Therapeutics made up 0.68% of Sectoral Asset Management's portfolio in Q1 2026, its #38 holding.
Sectoral Asset Management first reported a position in Nektar Therapeutics in Q1 2015 and has held it in 12 quarters since.
Sectoral Asset Management's Nektar Therapeutics position peaked at $10.5M in Q1 2018.
215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.